Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

Ana Jiménez-Ubieto; Alejandro Martín-Muñoz; María Poza; Sara Dorado; Almudena García-Ortiz; Enrique Revilla; Pilar Sarandeses; Yanira Ruiz-Heredia; Tycho Baumann; Antonia Rodríguez; María Calbacho; Pilar Martínez Sánchez; José María Sánchez Pina; Alejandro Martín García-Sancho; Gloria Figaredo; Daniel Gil-Alós; Laura Rufián; Margarita Rodríguez; Laura Carneros; Carolina Martínez-Laperche; Mariana Bastos-Oreiro; Chongwu Wang; María-Teresa Cedena; Inmaculada Rapado; Paula de Toledo; Miguel Gallardo; Antonio Valeri; Rosa Ayala; Joaquín Martínez-López; Santiago Barrio

doi:10.3389/fimmu.2023.1349296

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

Front Immunol. 2024 Jan 10:14:1349296. doi: 10.3389/fimmu.2023.1349296. eCollection 2023.

Authors

Ana Jiménez-Ubieto^#¹, Alejandro Martín-Muñoz^#^{1

2}, María Poza¹, Sara Dorado^{2

3}, Almudena García-Ortiz¹, Enrique Revilla⁴, Pilar Sarandeses⁵, Yanira Ruiz-Heredia^{1

2}, Tycho Baumann¹, Antonia Rodríguez¹, María Calbacho¹, Pilar Martínez Sánchez¹, José María Sánchez Pina¹, Alejandro Martín García-Sancho⁶, Gloria Figaredo¹, Daniel Gil-Alós¹, Laura Rufián^{1

2}, Margarita Rodríguez^{1

2}, Laura Carneros¹, Carolina Martínez-Laperche⁷, Mariana Bastos-Oreiro⁷, Chongwu Wang⁸, María-Teresa Cedena¹, Inmaculada Rapado¹, Paula de Toledo³, Miguel Gallardo¹, Antonio Valeri¹, Rosa Ayala¹, Joaquín Martínez-López¹, Santiago Barrio^{1

2}

Affiliations

¹ Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.
² Altum sequencing Co., Madrid, Spain.
³ Computational Science Department, Carlos III University, Madrid, Spain.
⁴ Departamento de Anatomía Patológica, Hospital Universitario 12 de Octubre, Madrid, Spain.
⁵ Departamento de Medicina Nuclear, Hospital Universitario 12 de Octubre, Madrid, Spain.
⁶ Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
⁷ Hospital General Universitario Gregorio Marañón, Madrid, Spain.
⁸ Hosea Precision Medical Technology Co., Ltd., Weihai, Shangdong, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1188818.].

Keywords: CAR T-cell therapy; NGS (Next-Generation Sequencing); PET/CT 18F-FDG; ctDNA (circulating tumor DNA); follicular lymphoma; minimal residual disease; monitoring.

Copyright © 2024 Jiménez-Ubieto, Martín-Muñoz, Poza, Dorado, García-Ortiz, Revilla, Sarandeses, Ruiz-Heredia, Baumann, Rodríguez, Calbacho, Sánchez, Pina, García-Sancho, Figaredo, Gil-Alós, Rufián, Rodríguez, Carneros, Martínez-Laperche, Bastos-Oreiro, Wang, Cedena, Rapado, de Toledo, Gallardo, Valeri, Ayala, Martínez-López and Barrio.

Publication types

Published Erratum